Role of viruses, alone and in association with bacteria, in adults hospitalized with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011
Role of virus in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012
Viral and mixed virus-bacteria community-acquired pneumonia (CAP) in hospitalized adults Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009
Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013
Human metapneumovirus and community-acquired pneumonia: a pediatric survey Source: Annual Congress 2005 - New insights in respiratory infections in children Year: 2005
Comparison of risk factors for childhood pneumonia with RSV versus other viruses Source: International Congress 2016 – Paediatric respiratory infections Year: 2016
The severity of Pneumocystis pneumonia without human immunodeficiency virus infection (non-HIV PCP) might be underestimated by conventional diagnostic rules for community-acquired pneumonia (CAP) Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Biomarkers to discriminate bacterial, viral and mixed community acquired pneumonia (CAP) Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011
Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia Source: Annual Congress 2007 - Infections year in review Year: 2007
Differences in prognostic factors and outcome in community-acquired pneumonias (CAP) caused by viral pathogens (VP) or streptococcus pneumoniae (SP) Source: Eur Respir J 2001; 18: Suppl. 33, 542s Year: 2001
Clinical characteristics and risk factors of virus or influenza infection among the hospitalized pneumonia in COPD patients Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016
The role of human neutrophil defensins in patients with pneumonia caused by influenza A (H1N1v) Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016
Modern etiology of severe community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
The impact of mixed etiology in community acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
Spread of carriage of pneumonia and acute respiratory diseases (ARS) agents in recruits Source: Eur Respir J 2005; 26: Suppl. 49, 144s Year: 2005
Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Seasonal distribution of acute respiratory tract infections (RTIs) due to respiratory syncytial virus (RSV), to Mycoplasma pneumonia (MP) and to Chlamydia pneumonia (CP) Source: Eur Respir J 2001; 18: Suppl. 33, 234s Year: 2001
Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP) Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
The role of Chlamydiae spp. in respiratory infections Source: Annual Congress 2005 - Difficult infections in the respiratory patient Year: 2005
Surfactant-enforced treatment of pseudomonas -induced pneumonia Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013